DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis
Europe - BIT:CPR - NL0015435975 - Common Stock
5.681 EUR
-0.04 (-0.61%)
We assign a fundamental rating of 3 out of 10 to CPR. CPR was compared to 27 industry peers in the Beverages industry. CPR has an average financial health and profitability rating. CPR is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CPR had positive earnings in the past year.
In the past year CPR had a positive cash flow from operations.
CPR had positive earnings in each of the past 5 years.
CPR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CPR has a Return On Assets of 2.38%. This is in the lower half of the industry: CPR underperforms 66.67% of its industry peers.
With a Return On Equity value of 5.23%, CPR is not doing good in the industry: 74.07% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 6.63%, CPR is in line with its industry, outperforming 48.15% of the companies in the same industry.
CPR had an Average Return On Invested Capital over the past 3 years of 7.66%. This is in line with the industry average of 8.63%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.38% | ||
| ROE | 5.23% | ||
| ROIC | 6.63% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
1.3 Margins
CPR's Profit Margin of 6.57% is in line compared to the rest of the industry. CPR outperforms 40.74% of its industry peers.
In the last couple of years the Profit Margin of CPR has declined.
CPR's Operating Margin of 21.32% is in line compared to the rest of the industry. CPR outperforms 55.56% of its industry peers.
In the last couple of years the Operating Margin of CPR has remained more or less at the same level.
With a decent Gross Margin value of 57.55%, CPR is doing good in the industry, outperforming 74.07% of the companies in the same industry.
CPR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% |
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
CPR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CPR has more shares outstanding
CPR has more shares outstanding than it did 5 years ago.
CPR has about the same debt/assets ratio as last year.
2.2 Solvency
An Altman-Z score of 2.40 indicates that CPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.40, CPR is doing good in the industry, outperforming 62.96% of the companies in the same industry.
The Debt to FCF ratio of CPR is 13.61, which is on the high side as it means it would take CPR, 13.61 years of fcf income to pay off all of its debts.
CPR's Debt to FCF ratio of 13.61 is on the low side compared to the rest of the industry. CPR is outperformed by 66.67% of its industry peers.
A Debt/Equity ratio of 0.66 indicates that CPR is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.66, CPR is doing good in the industry, outperforming 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 13.61 | ||
| Altman-Z | 2.4 |
ROIC/WACC0.99
WACC6.69%
2.3 Liquidity
A Current Ratio of 2.37 indicates that CPR has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.37, CPR belongs to the best of the industry, outperforming 81.48% of the companies in the same industry.
A Quick Ratio of 0.99 indicates that CPR may have some problems paying its short term obligations.
CPR's Quick ratio of 0.99 is amongst the best of the industry. CPR outperforms 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
CPR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.50%.
CPR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.12% yearly.
The Revenue has been growing slightly by 5.18% in the past year.
CPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.75% yearly.
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%N/A
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%N/A
3.2 Future
Based on estimates for the next years, CPR will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.33% on average per year.
The Revenue is expected to grow by 4.81% on average over the next years.
EPS Next Y-0.58%
EPS Next 2Y4.32%
EPS Next 3Y6.88%
EPS Next 5Y11.33%
Revenue Next Year2.52%
Revenue Next 2Y2.84%
Revenue Next 3Y3.72%
Revenue Next 5Y4.81%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 33.42, the valuation of CPR can be described as expensive.
Based on the Price/Earnings ratio, CPR is valued a bit more expensive than the industry average as 77.78% of the companies are valued more cheaply.
When comparing the Price/Earnings ratio of CPR to the average of the S&P500 Index (27.20), we can say CPR is valued slightly more expensively.
The Price/Forward Earnings ratio is 17.58, which indicates a rather expensive current valuation of CPR.
CPR's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CPR is more expensive than 62.96% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, CPR is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.42 | ||
| Fwd PE | 17.58 |
4.2 Price Multiples
CPR's Enterprise Value to EBITDA is on the same level as the industry average.
62.96% of the companies in the same industry are cheaper than CPR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 33.25 | ||
| EV/EBITDA | 12.61 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.32%
EPS Next 3Y6.88%
5. Dividend
5.1 Amount
CPR has a Yearly Dividend Yield of 1.15%. Purely for dividend investing, there may be better candidates out there.
With a Dividend Yield of 1.15, CPR pays less dividend than the industry average, which is at 2.85. 81.48% of the companies listed in the same industry pay a better dividend than CPR!
With a Dividend Yield of 1.15, CPR pays less dividend than the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.15% |
5.2 History
The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CPR pays out 38.74% of its income as dividend. This is a sustainable payout ratio.
DP38.74%
EPS Next 2Y4.32%
EPS Next 3Y6.88%
BIT:CPR (9/18/2025, 4:17:15 PM)
5.681
-0.04 (-0.61%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)
Earnings (Next)
Inst Owners21.06%
Inst Owner ChangeN/A
Ins Owners52%
Ins Owner ChangeN/A
Market Cap6.99B
Analysts70
Price Target6.99 (23.04%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.15% |
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.74%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.54%
PT rev (3m)-0.65%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.87%
EPS NY rev (3m)-1.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.29%
Revenue NY rev (3m)-2.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.42 | ||
| Fwd PE | 17.58 | ||
| P/S | 2.28 | ||
| P/FCF | 33.25 | ||
| P/OCF | 10.43 | ||
| P/B | 1.82 | ||
| P/tB | 153.4 | ||
| EV/EBITDA | 12.61 |
EPS(TTM)0.17
EY2.99%
EPS(NY)0.32
Fwd EY5.69%
FCF(TTM)0.17
FCFY3.01%
OCF(TTM)0.54
OCFY9.59%
SpS2.49
BVpS3.13
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.38% | ||
| ROE | 5.23% | ||
| ROCE | 9.04% | ||
| ROIC | 6.63% | ||
| ROICexc | 6.65% | ||
| ROICexgc | 14.09% | ||
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% | ||
| FCFM | 6.85% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexcg growth 3Y-20.45%
ROICexcg growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score4
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 13.61 | ||
| Debt/EBITDA | 3.27 | ||
| Cap/Depr | 360.3% | ||
| Cap/Sales | 14.99% | ||
| Interest Coverage | 6.99 | ||
| Cash Conversion | 85.71% | ||
| Profit Quality | 104.37% | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | 2.4 |
F-Score4
WACC6.69%
ROIC/WACC0.99
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%N/A
EPS Next Y-0.58%
EPS Next 2Y4.32%
EPS Next 3Y6.88%
EPS Next 5Y11.33%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%N/A
Revenue Next Year2.52%
Revenue Next 2Y2.84%
Revenue Next 3Y3.72%
Revenue Next 5Y4.81%
EBIT growth 1Y6.42%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year23.05%
EBIT Next 3Y13.08%
EBIT Next 5Y10.6%
FCF growth 1Y232.49%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y328.44%
OCF growth 3Y11.5%
OCF growth 5Y13.06%